meclofenamic acid and temozolomide

meclofenamic acid has been researched along with temozolomide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jiang, S; Li, X; Mu, Z; Xiao, L; Xie, C; Zhou, J; Zhou, P	1
Becker, A; Burger, MC; Clusmann, H; Delev, D; Giordano, FA; Glas, M; Goldbrunner, R; Grauer, O; Güresir, E; Hau, P; Heiland, DH; Herrlinger, U; Krex, D; Nemeth, R; Potthoff, AL; Radbruch, A; Sabel, M; Schaub, C; Schilling, J; Schlegel, U; Schmid, M; Schneider, M; Schnell, O; Schuss, P; Seidel, C; Steinbach, JP; Tabatabai, G; Thon, N; Vatter, H; Weller, J; Winkler, F; Zeyen, T	1

Reviews

1 review(s) available for meclofenamic acid and temozolomide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for meclofenamic acid and temozolomide

Article	Year
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial. Trials, 2022, Jan-19, Volume: 23, Issue:1 Topics: Antineoplastic Agents, Alkylating; DNA Modification Methylases; DNA Repair Enzymes; Glioblastoma; Humans; Meclofenamic Acid; Neoplasm Recurrence, Local; Temozolomide; Tumor Suppressor Proteins	2022

Other Studies

1 other study(ies) available for meclofenamic acid and temozolomide

Article	Year
FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155/23a Cluster-MXI1 Feedback Circuit in Glioma. Cancer research, 2020, 09-15, Volume: 80, Issue:18 Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Antineoplastic Agents, Alkylating; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase Inhibitors; Drug Synergism; Feedback, Physiological; Female; Glioma; Humans; Meclofenamic Acid; Mice; Mice, Nude; MicroRNAs; Neoplasm Transplantation; Proto-Oncogene Proteins c-myc; Temozolomide; Tumor Suppressor Proteins	2020

Article

Year

FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155/23a Cluster-MXI1 Feedback Circuit in Glioma.

Cancer research, 2020, 09-15, Volume: 80, Issue:18

Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Antineoplastic Agents, Alkylating; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase Inhibitors; Drug Synergism; Feedback, Physiological; Female; Glioma; Humans; Meclofenamic Acid; Mice; Mice, Nude; MicroRNAs; Neoplasm Transplantation; Proto-Oncogene Proteins c-myc; Temozolomide; Tumor Suppressor Proteins

2020